Analysts predict that Universal Health Services (NYSE:UHS) will report $2.74 billion in sales for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Universal Health Services’ earnings, with estimates ranging from $2.70 billion to $2.77 billion. Universal Health Services posted sales of $2.61 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 5%. The company is expected to issue its next quarterly earnings report after the market closes on Tuesday, April 24th.
On average, analysts expect that Universal Health Services will report full-year sales of $10.97 billion for the current year, with estimates ranging from $10.79 billion to $11.04 billion. For the next financial year, analysts forecast that the business will report sales of $11.53 billion per share, with estimates ranging from $11.25 billion to $11.72 billion. Zacks’ sales calculations are an average based on a survey of research firms that cover Universal Health Services.
Universal Health Services (NYSE:UHS) last issued its quarterly earnings data on Wednesday, February 28th. The health services provider reported $2.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.84 by $0.16. The business had revenue of $2.64 billion during the quarter, compared to the consensus estimate of $2.64 billion. Universal Health Services had a return on equity of 15.06% and a net margin of 7.23%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.80 earnings per share.
Several equities analysts have recently issued reports on the company. Royal Bank of Canada reiterated a “buy” rating and set a $134.00 price objective on shares of Universal Health Services in a research report on Thursday, January 4th. Stephens set a $120.00 target price on Universal Health Services and gave the stock a “hold” rating in a research report on Thursday, March 1st. BMO Capital Markets restated an “outperform” rating and issued a $130.00 target price (up from $125.00) on shares of Universal Health Services in a research report on Friday, March 2nd. Zacks Investment Research upgraded Universal Health Services from a “hold” rating to a “buy” rating and set a $135.00 target price for the company in a research report on Wednesday, January 31st. Finally, Mizuho set a $137.00 target price on Universal Health Services and gave the stock a “buy” rating in a research report on Wednesday, January 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating and twelve have assigned a buy rating to the stock. Universal Health Services has an average rating of “Buy” and an average price target of $133.40.
Several hedge funds and other institutional investors have recently bought and sold shares of UHS. Russell Investments Group Ltd. increased its holdings in shares of Universal Health Services by 15.8% in the third quarter. Russell Investments Group Ltd. now owns 23,066 shares of the health services provider’s stock valued at $2,559,000 after buying an additional 3,150 shares in the last quarter. Macquarie Group Ltd. raised its stake in Universal Health Services by 103.0% during the 3rd quarter. Macquarie Group Ltd. now owns 3,351 shares of the health services provider’s stock valued at $371,000 after purchasing an additional 1,700 shares during the period. Dimensional Fund Advisors LP raised its stake in Universal Health Services by 5.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,210,413 shares of the health services provider’s stock valued at $134,272,000 after purchasing an additional 60,415 shares during the period. Magnetar Financial LLC acquired a new stake in Universal Health Services during the 3rd quarter valued at $434,000. Finally, Vident Investment Advisory LLC acquired a new stake in Universal Health Services during the 3rd quarter valued at $832,000. 88.19% of the stock is currently owned by institutional investors.
Shares of NYSE UHS traded up $1.17 during midday trading on Friday, hitting $120.81. 250,724 shares of the company’s stock were exchanged, compared to its average volume of 819,363. The company has a current ratio of 0.97, a quick ratio of 0.90 and a debt-to-equity ratio of 0.69. The company has a market cap of $11,278.22, a PE ratio of 15.93, a P/E/G ratio of 1.16 and a beta of 0.83. Universal Health Services has a twelve month low of $95.26 and a twelve month high of $128.15.
TRADEMARK VIOLATION NOTICE: This story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://ledgergazette.com/2018/04/16/2-74-billion-in-sales-expected-for-universal-health-services-uhs-this-quarter.html.
Universal Health Services Company Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. The company operates through Acute Care Hospital Services, Behavioral Health Care Services, and Other segments. Its hospital offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.